
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : NFX Bio
Deal Size : $13.4 million
Deal Type : Financing
Radar Therapeutics Raises $13.4M in Seed Funding for Programmable Medicines
Details : The financing will support advancement of Radar’s internal programs including, programmable genetic and mRNA-based therapeutics that use RNA sensors for autoimmune diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 23, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : NFX Bio
Deal Size : $13.4 million
Deal Type : Financing
